Commercial

Top 25 rare disease brands, by sales

Teva Pharmaceutical Industries' Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.

February 15, 2017

3:35 pm

From the March 01, 2017 Issue of MM+M - Medical Marketing and Media

From Our Partners

Partner Content

Why data-driven linear is the last piece of the marketing puzzle

Reduce waste, optimize media and achieve cross-channel attribution by unifying television.

Partner Content

Fifth CIIE to bring strong Chinese market to global pharmaceutical enterprises

The Medical Equipment and Healthcare Products exhibition area at the CIIE has become an important platform for global pharmaceutical enterprises to explore the Chinese market and share development opportunities in China.

Partner Content

Video: Why privacy changes demand a better approach to targeting: Real world data

Building custom audience segments can help marketers better reach consumers.

Partner Content

An all-in agency approach to challenging the status quo in oncology marketing

Differentiating science, technology, and brand innovation has never been more important across complex and crowded specialty markets.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Top 25 rare disease brands, by sales

MM+M Media Summit 2022

From Our Partners

Partner Content

Why data-driven linear is the last piece of the marketing puzzle

Partner Content

Fifth CIIE to bring strong Chinese market to global pharmaceutical enterprises

Partner Content

Video: Why privacy changes demand a better approach to targeting: Real world data

Partner Content

An all-in agency approach to challenging the status quo in oncology marketing

Thank you for accessing MM+M.